Objective <p>This study investigates how retinoic acid (RA) promotes osteogenic differentiation in mouse facial suture mesenchymal stem cells (MSCs) under mechanical stretching, focusing on the mechanosensitive ion channel <i>Piezo2</i>. We investigate the mechanism underlying the synergistic effects of RA and mechanical stimuli on osteogenic differentiation of MSCs, a process crucial for bone regeneration in craniofacial hypoplasia.</p> Methods <p>Mouse suture MSCs were mechanically stretched with or without RA co-treatment. RNA-seq analyzed gene expression, followed by Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs). Cell stretching and RA-treated murine models were used to validate the findings. Additionally, <i>Piezo2</i>-knockdown MSCs were exposed to mechanical stretching under osteogenic induction conditions to assess depositions of mineralized sites.</p> Results <p>Micro-CT and Immunohistochemistry showed RA-stretch co-treatment significantly widened the zygomaticomaxillary suture (ZMS) compared to controls. This combined treatment induced the expression of osteogenic marker genes. RNA-seq analysis identified <i>Piezo2</i> as a highly upregulated gene (<i>p</i> &lt; 0.0001; Log2(Fold Change) = 4.91), with RT-qPCR validation confirming 8.38-fold higher <i>Piezo2</i> expression in RA-stretch co-treatment groups (<i>p</i> &lt; 0.001). Crucially, <i>Piezo2</i> knockdown prevented the osteogenic differentiation induced by RA and mechanical stretching, evidenced by reduced depositions of mineralized sites.</p> Conclusion <p>These findings indicate that RA promotes osteogenic differentiation of MSCs under mechanical stretching, predominantly through the upregulation of <i>Piezo2.</i> This study provides novel insights into the molecular mechanisms underlying Trans-sutural Distraction Osteogenesis (TSDO) and highlights the potential of RA as an adjunctive therapy for enhancing bone regeneration in craniofacial hypoplasia.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Retinoic Acid Promotes Osteogenic Differentiation of Mesenchymal Stem Cells in the Mouse Facial Suture under Mechanical Stretching via Piezo2

  • Zheng Wang,
  • Guanhuier Wang,
  • Mengying Jin,
  • Yujie Chen,
  • Wenfang Dong,
  • Pengbing Ding,
  • Zhenmin Zhao

摘要

Objective

This study investigates how retinoic acid (RA) promotes osteogenic differentiation in mouse facial suture mesenchymal stem cells (MSCs) under mechanical stretching, focusing on the mechanosensitive ion channel Piezo2. We investigate the mechanism underlying the synergistic effects of RA and mechanical stimuli on osteogenic differentiation of MSCs, a process crucial for bone regeneration in craniofacial hypoplasia.

Methods

Mouse suture MSCs were mechanically stretched with or without RA co-treatment. RNA-seq analyzed gene expression, followed by Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs). Cell stretching and RA-treated murine models were used to validate the findings. Additionally, Piezo2-knockdown MSCs were exposed to mechanical stretching under osteogenic induction conditions to assess depositions of mineralized sites.

Results

Micro-CT and Immunohistochemistry showed RA-stretch co-treatment significantly widened the zygomaticomaxillary suture (ZMS) compared to controls. This combined treatment induced the expression of osteogenic marker genes. RNA-seq analysis identified Piezo2 as a highly upregulated gene (p < 0.0001; Log2(Fold Change) = 4.91), with RT-qPCR validation confirming 8.38-fold higher Piezo2 expression in RA-stretch co-treatment groups (p < 0.001). Crucially, Piezo2 knockdown prevented the osteogenic differentiation induced by RA and mechanical stretching, evidenced by reduced depositions of mineralized sites.

Conclusion

These findings indicate that RA promotes osteogenic differentiation of MSCs under mechanical stretching, predominantly through the upregulation of Piezo2. This study provides novel insights into the molecular mechanisms underlying Trans-sutural Distraction Osteogenesis (TSDO) and highlights the potential of RA as an adjunctive therapy for enhancing bone regeneration in craniofacial hypoplasia.